Related Experiment Video
Updated: Feb 3, 2026

Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development
Published on: July 1, 2020
Samp1 Mislocalization in Emery-Dreifuss Muscular Dystrophy
Elisabetta Mattioli1,2, Marta Columbaro3, Mohammed Hakim Jafferali4
1CNR Institute of Molecular Genetics, Unit of Bologna, 40136 Bologna, Italy. emattiol@area.bo.cnr.it.
Spindle Associated Membrane Protein 1 (Samp1) anchorage is disrupted in Emery-Dreifuss muscular dystrophy (EDMD2) due to LMNA mutations. This finding reveals Samp1 as a new contributor to EDMD2 pathogenesis and nuclear clustering in laminopathic muscle.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Emery-Dreifuss muscular dystrophy type 2 (EDMD2) is a rare genetic disorder affecting muscle function, characterized by weakness, wasting, and cardiac conduction defects.
- Mutations in the LMNA gene, encoding lamin A/C, are associated with EDMD2, impacting nuclear envelope integrity and function.
- The Linker of Nucleoskeleton and Cytoskeleton (LINC) complex and Spindle Associated Membrane Protein 1 (Samp1) are nuclear envelope proteins potentially involved in EDMD2 pathogenesis.
Purpose of the Study:
- To investigate the role of Samp1 in the context of EDMD2 and its relationship with lamin A/C and the LINC complex.
- To determine if Samp1 localization and anchorage at the nuclear envelope are affected in EDMD2 patient-derived myotubes.
- To elucidate the upstream or downstream relationship between Samp1 and other nuclear envelope components like SUN1 in muscle cells.
Main Methods:
- Immunofluorescence microscopy was used to examine the distribution of Samp1 in normal human myotubes, committed myoblasts, and EDMD2 myotubes.
- Analysis of Samp1 anchorage at nuclear poles in relation to farnesylated prelamin A and the impact of prelamin A farnesylation loss.
- Comparison of Samp1 localization in EDMD2 myotubes with that in myotubes carrying pathogenic SUN1 mutations.
Main Results:
- Samp1 exhibits uniform distribution at the nuclear periphery of normal myotubes and myoblasts.
- Samp1 anchorage at nuclear poles depends on farnesylated prelamin A and is disrupted by its loss.
- Samp1 is absent from nuclear poles in EDMD2 myotubes, indicating that LMNA mutations impair Samp1 anchorage.
- SUN1 mutations do not affect Samp1 localization, suggesting Samp1 acts upstream of SUN1.
Conclusions:
- Samp1 is identified as a novel contributor to the pathogenesis of EDMD2.
- LMNA mutations in EDMD2 disrupt Samp1 anchorage at the nuclear envelope, contributing to muscle pathology.
- The findings provide insights into nuclear clustering mechanisms in laminopathic muscle diseases and suggest a potential role for Samp1 in regulating microtubule nucleation at the nuclear envelope.
More Related Videos
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
The Muscular System
Acids, Bases and Neutralization Reactions

